Benlazar S M A, Professor of hematology, Universitary hospital of Sidi Bel Abbés, shared an article by Nicholas J Short on X:
“Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial – The Lancet Haematology.”